(nitroglycerin 0.6 mg) Dailymed
Generic: is used for the treatment of Duodenal Ulcer Esophagitis, Peptic Gastroesophageal Reflux Gastrointestinal Hemorrhage Stomach Ulcer Zollinger-Ellison Syndrome
IMPRINT: N 6
SHAPE: round
COLOR: white
All Imprints
frovatriptan succinate 2.5 mg - e 2 5 round white
dipyridamole 75 mg - 19 round orange
aspirin 325 mg - aspirin 44 249 round white
valsartan 80 mg - 7432 tv round pink
calcium fluoride 30 [hp_x] - round white
captopril 100 mg - w 905 round white
levodopa 50 mgentacapone 200 mgcarbidopa 12.5 mg - w782 round brown
calcium acetate 667 mg - p113 round white
lithium carbonate 300 mg - ww 300 round white
cyclophosphamide 25 mg - 54 639 round blue
methylphenidate hydrochloride 10 mg - ciba 3 round green
desloratadine 5 mg - 5 round blue
carvedilol 25 mg - zc42 round white
iloperidone 8 mg - 8 round white
glyburide 2.5 mg - cor 124 round yellow
bismuth subsalicylate 262 mg - rh046 round pink
moexipril hydrochloride 7.5 mg - apo moe 7 5 round white
- r221 round orange
venlafaxine hydrochloride 50 mg - ip 303 round orange
pseudoephedrine hydrochloride 30 mg - tcl016 round red
donepezil hydrochloride 5 mg - i 24 round white
methadone hydrochloride 5 mg - u41 round white
donepezil hydrochloride 10 mg - i 21 round yellow
amlodipine besylate 2.5 mgatorvastatin calcium trihydrate 20 mg - pfizer cdt 252 round white
chlorpheniramine maleate 4 mg - 44 194 round yellow
tamoxifen citrate 20 mg - m 274 round white
hydrochlorothiazide 50 mg - h 3 round orange
pitavastatin calcium 4.18 mg - 4 kc round white
venlafaxine hydrochloride 25 mg - 6147 v round orange
docusate sodium 50 mgsennosides a and b 8.6 mg - tcl081 round orange
quinidine gluconate 324 mg - mp 66 round white
oxycodone hydrochloride 7.5 mgacetaminophen 325 mg - watson 933 round white
cyclobenzaprine hydrochloride 5 mg - tl 211 round orange
trihexyphenidyl hydrochloride 2 mg - 5971 v round white
lamotrigine 50 mg - h009 round orange
rabeprazole sodium 20 mg - 107 round yellow
carbamazepine 200 mg - t 200 mg round pink
enalapril maleate 5 mghydrochlorothiazide 12.5 mg - apo 5 12 5 round red
diclofenac sodium 100 mg - r 717 round yellow
minoxidil 10 mg - dan 5643 10 round white
acetaminophen 500 mg - ap 013 round white
levonorgestrel 0.1 mgethinyl estradiol 0.02 mg - b 965 round pink
clonazepam 0.5 mg - 832 teva round yellow
oxcarbazepine 300 mg - 54 515 round orange
fludrocortisone acetate 0.1 mg - 7033 round white
atovaquone 250 mgproguanil hydrochloride 100 mg - gx cm3 round pink
lamotrigine 50 mg - lamictal xr 50 round green
maprotiline hydrochloride 75 mg - 9 2 m round white
candesartan cilexetil 4 mg - acf 004 round white
memantine hydrochloride 5 mg - m5 v round white
lamotrigine 150 mg - lam 150 apo round yellow
acarbose 50 mg - precose 50 round white
docusate sodium 50 mgsennosides 8.6 mg - tcl 131 round purple
dextroamphetamine saccharate 3.75 mgamphetamine aspartate monohydrate 3.75 mgdextroamphetamine sulfate 3.75 mgamphetamine sulfate 3.75 mg - b 777 1 5 round orange
paroxetine hydrochloride hemihydrate 25 mg - gsk 25 round pink
bupropion hydrochloride 100 mg - wellbutrin 100 round red
memantine hydrochloride 10 mg - m10 x round white
dextroamphetamine saccharate 2.5 mgamphetamine aspartate monohydrate 2.5 mgdextroamphetamine sulfate 2.5 mgamphetamine sulfate 2.5 mg - 1 0 dp round blue
nifedipine 60 mg - 60 adalat cc round pink
lisinopril 10 mghydrochlorothiazide 12.5 mg - lh1 m round white
alprazolam 1 mg - cor 188 round yellow
liothyronine sodium 50 ug - 50 223 round white
venlafaxine hydrochloride 75 mg - 6150 v round orange
metoprolol tartrate 50 mg - c 74 round pink
prednisone 10 mg - west ward 473 round white
trandolapril 2 mg - fx round yellow
pitavastatin calcium 1 mg - 1 kc round white
dextroamphetamine saccharate 3.125 mgamphetamine aspartate monohydrate 3.125 mgdextroamphetamine sulfate 3.125 mgamphetamine sulfate 3.125 mg - 12 5 d p round orange
benztropine mesylate 2 mg - b 1116 round white
chlorpheniramine maleate 12 mg - chlorphen 12 round orange
lisinopril 10 mg - ww 267 round pink
paroxetine hydrochloride hemihydrate 37.5 mg - gsk 37 5 round blue
naproxen 250 mg - 93 147 round red
morphine sulfate 60 mg - m ms 60 round orange
hydrocodone bitartrate 7.5 mgibuprofen 200 mg - 3585 v round white
warfarin sodium 2 mg - ig w 2 round purple
galantamine hydrobromide 12 mg - janssen g 12 round brown
methazolamide 50 mg - eff 20 round white
simvastatin 10 mg - sv 10 round pink
norethindrone 1 mgethinyl estradiol 0.035 mg - b 949 round yellow
potassium chloride 600 mg - ktab round yellow
famciclovir 250 mg - 8118 93 round white
progesterone 100 mg - sv round orange
isosorbide dinitrate 10 mg - gg26 round white
flecainide acetate 50 mg - an 641 round white
buspirone hydrochloride 10 mg - teva 54 round white
topiramate 50 mg - apo tp 50 round yellow
simvastatin 40 mg - sv 40 round pink
isosorbide dinitrate 5 mg - bpi 152 round pink
- b 247 round brown
clonazepam 0.25 mg - b 95 1 4 round white
prednisolone sodium phosphate 30 mg - ora 30 round white
nifedipine 30 mg - m 475 round pink
alendronate sodium 5 mg - 93 5140 round white
chloroquine phosphate 250 mg - 0115 2790 round white
acarbose 25 mg - precose 25 round white
bumetanide 1 mg - e 129 round yellow
levomefolate calcium 0.451 mg - m round orange
flavoxate hydrochloride 100 mg - 58 round white
verapamil hydrochloride 80 mg - watson 343 round white
desipramine hydrochloride 10 mg - 68 7 round blue
levonorgestrel 0.15 mgethinyl estradiol 0.02 mg - tv 076 round pink
atenolol 25 mg - 787 teva round white
dipyridamole 75 mg - c83 round white
hydrocortisone 10 mg - cp 332 round white
desipramine hydrochloride 75 mg - e 722 round blue
citalopram hydrobromide 10 mg - mx31 round orange
lamotrigine 150 mg - taro lmt 150 round white
- 54-980 round blue
topiramate 25 mg - ig 278 round white
hydroxyzine hydrochloride 50 mg - tv 309 round white
cefuroxime axetil 250 mg - w 921 round white
acarbose 25 mg - 54 311 round white
lamotrigine 100 mg - j 246 round white
sennosides a and b 8.6 mg - gpi w2 round brown
metformin hydrochloride 500 mg - h 102 round white
olanzapine 5 mg - m oe1 round yellow
zolpidem tartrate 12.5 mg - a1 round yellow
bupropion hydrochloride 100 mg - g 2442 round yellow
- dan 5540 round white
hydromorphone hydrochloride 4 mg - m 4 round white
phytonadione 5 mg - aton 405 mephyton round yellow
nifedipine 30 mg - 30 adalat cc round pink
tramadol hydrochloride 200 mg - 200 er round white
cinchona officinalis bark 30 [hp_c]coffea arabica fruit 6 [hp_c]strychnos nux-vomica seed 30 [hp_c]matricaria chamomilla flowering top oil 6 [hp_c]artemisia cina flower 30 [hp_c] - none round white
paroxetine hydrochloride hemihydrate 10 mg - zc 15 round white
hydralazine hydrochloride 50 mg - par 028 round orange
benazepril hydrochloride 10 mg - apo be 10 round yellow
propafenone hydrochloride 225 mg - 5125 v round white
eszopiclone 1 mg - 93 e7 round blue
carbinoxamine maleate 4 mg - bp 605 round white
metronidazole 250 mg - 3969 wpi round white
oxybutynin chloride 10 mg - g342 round pink
ethinyl estradiol 0.01 mg - b 556 round yellow
hydrochlorothiazide 6.25 mgbisoprolol fumarate 2.5 mg - ul l round yellow
metoprolol tartrate 100 mg - re 76 round white
aripiprazole 30 mg - tv 7583 round pink
ropinirole hydrochloride 2 mg - 54 231 round orange
- west-ward 248 round yellow
acetaminophen 300 mgcodeine phosphate 15 mg - 2 m round white
calcium carbonate 750 mg - fc round green
levocetirizine dihydrochloride 5 mg - 161 h round white
glipizide 2.5 mg - wpi 900 round orange
torsemide 20 mg - pa 917 round white
olanzapine 7.5 mg - m 335 round white
metformin hydrochloride 500 mg - andrx 674 500 round white
norethindrone acetate 1.5 mgethinyl estradiol 30 ug - b 978 round pink
azathioprine 50 mg - 54 043 round yellow
bupropion hydrochloride 100 mg - apo bup 100 round purple
estradiol 0.5 mg - watson 528 round white
olanzapine 20 mg - tv u4 20 round yellow
levonorgestrel 1.5 mg - g00 round white
nitazoxanide 500 mg - alinia 500 round yellow
zolmitriptan 5 mg - f11 round white
paroxetine hydrochloride hemihydrate 30 mg - m n3 round blue
doxazosin mesylate 8 mg - n 598 8 round white
hydrochlorothiazide 50 mg - 3572 v round orange
levonorgestrel 0.075 mgethinyl estradiol 0.040 mg - dp 511 round white
glipizide 10 mg - 10 round white
norethindrone acetate 1 mgethinyl estradiol 20 ug - b 711 round pink
imipramine hydrochloride 50 mg - par 56 round green
repaglinide 1 mg - p241 round yellow
felodipine 2.5 mg - 450 plendil round green
ciprofloxacin hydrochloride 250 mg - cr 250 round white
pravastatin sodium 10 mg - teva 771 round pink
prednisone 20 mg - tl175 round pink
ethinyl estradiol 0.01 mg - dp 457 round yellow
calcium carbonate 420 mg - az 036 round white
alprazolam 0.5 mg - cor 187 round white
haloperidol 0.5 mg - mylan 351 round orange
midodrine hydrochloride 5 mg - g 422 round orange
carvedilol 12.5 mg - zc41 round white
metformin hydrochloride 850 mg - andrx 675 850 round white
desipramine hydrochloride 25 mg - e 19 round blue
olanzapine 5 mg - tv u1 5 round yellow
felodipine 10 mg - 452 plendil round red
flecainide acetate 50 mg - rx794 round white
fosinopril sodium 40 mg - 202 ig round white
rabeprazole sodium 20 mg - aciphex 20 round yellow
zolpidem tartrate 5 mg - m z1 round purple
metoprolol succinate 100 mg - a ms round white
leucovorin calcium 15 mg - 54 650 round yellow
amoxapine 50 mg - dan 50 5714 round orange
clozapine 100 mg - clozaril 100 round yellow
leucovorin calcium 25 mg - 54 013 round yellow
tramadol hydrochloride 300 mg - 300 er round white
tolterodine tartrate 2 mg - dt round white
doxycycline 50 mg - lci 1335 round yellow
minoxidil 10 mg - 10 mp 89 round white
aspirin 81 mg - az 013 round orange
lorazepam 2 mg - 242 2 watson round white
trandolapril 4 mg - tn4 round white
propranolol hydrochloride 60 mg - 54 85 v round pink
dimethicone 80 mgcalcium carbonate 750 mg - dr round pink
prochlorperazine maleate 10 mg - tl115 round green
dexamethasone 1.5 mg - 54 943 round pink
ranitidine hydrochloride 150 mg - gg 705 round pink
sodium fluoride 0.5 mg - sci 1007 round white
prednisone 5 mg - westward 475 round white
alprazolam 2 mg - sp 324 2 round white
pioglitazone hydrochloride 15 mg - actos 15 round white
aspirin 162 mgacetaminophen 110 mgsalicylamide 152 mgcaffeine 32.4 mg - fr2 round orange
meloxicam 7.5 mg - zc 25 round yellow
metolazone 2.5 mg - m 172 round orange
amlodipine besylate 5 mgolmesartan medoxomil 40 mg - c75 round white
ondansetron hydrochloride 8 mg - r 154 round yellow
diclofenac sodium 75 mgmisoprostol 200 ug - 0398 round white
sitagliptin phosphate 100 mg - 277 round brown
acarbose 25 mg - e71 round white
albuterol sulfate 4 mg - mp 88 round white
topiramate 50 mg - omn 50 round yellow
dextroamphetamine saccharate 5 mgamphetamine aspartate monohydrate 5 mgdextroamphetamine sulfate 5 mgamphetamine sulfate 5 mg - e 401 round orange
trifluoperazine hydrochloride 2 mg - m t4 round white
oxycodone hydrochloride 20 mg - op 20 round pink
citalopram hydrobromide 10 mg - 206 ig round yellow
trazodone hydrochloride 100 mg - pliva 434 round white
zolmitriptan 2.5 mg - zomig 25 round yellow
desipramine hydrochloride 50 mg - e 721 round blue
dextroamphetamine saccharate 7.5 mgamphetamine aspartate monohydrate 7.5 mgdextroamphetamine sulfate 7.5 mgamphetamine sulfate 7.5 mg - e 404 round orange
trazodone hydrochloride 100 mg - apo t100 round white
hydralazine hydrochloride 100 mg - hp 4 round pink
meclizine hydrochloride 25 mg - m mcz 25 round white
levetiracetam 250 mg - m 613 round white
alendronate sodium 35 mg - 637 round white
dexamethasone 0.5 mg - 54 299 round yellow
carbidopa 25 mglevodopa 100 mg - apo 25 100 round yellow
norethindrone 0.5 mgethinyl estradiol 0.035 mg - b 941 round yellow
irbesartan 75 mg - m in1 round white
calcium ascorbate 50 mgcalcium threonate 50 mgcholecalciferol 6 ug.alpha.-tocopherol acetate, dl- 3.5 [iu]pyridoxine hydrochloride 2 mgfolic acid 1 mgcalcium carbonate 250 mgferrous fumarate 40 mgmagnesium oxide 50 mgzinc oxide 15 mgcupric oxide 2 mg - tl014 round grey
hydromorphone hydrochloride 2 mg - p 2 round orange
norethindrone acetate 1 mgethinyl estradiol .02 mg - 93 912 round white
sodium starch glycolate type a corn 3.61 mgpovidone k30 5.415 mgstearic acid 1.805 mgacetaminophen 324.9 mgstarch, corn 25.27 mg - 325 round white
megestrol acetate 20 mg - par 289 round white
propranolol hydrochloride 40 mg - 54 84 v round green
tinidazole 250 mg - tm 250 round pink
lisinopril 40 mg - 3761 round white
escitalopram oxalate 10 mg - 11 36 round white
amitriptyline hydrochloride 75 mg - m 37 round blue
medroxyprogesterone acetate 2.5 mg - g3740 round orange
amlodipine besylate 5 mgvalsartan 160 mghydrochlorothiazide 25 mg - tv 7037 round yellow
trihexyphenidyl hydrochloride 2 mg - dan dan 5335 round white
amitriptyline hydrochloride 100 mg - 2105 v round red
acarbose 100 mg - e73 round white
norethindrone 1 mgethinyl estradiol 0.035 mg - b 943 round orange
lorazepam 2 mg - mylan 777 round white
bisoprolol fumarate 5 mghydrochlorothiazide 6.25 mg - b 50 round pink
oxycodone hydrochloride 15 mg - m 15 round green
repaglinide 1 mg - 745 c round yellow
butalbital 50 mgacetaminophen 325 mgcaffeine 40 mg - lci 1695 round blue
aripiprazole 30 mg - a 011 30 round pink
levonorgestrel 0.15 mgethinyl estradiol 0.03 mg - b 555 round blue
glipizide 10 mg - glipizide xl 10 round white
olanzapine 2.5 mg - m 157 round orange
promethazine hydrochloride 50 mg - zc03 round white
zolmitriptan 5 mg - zomig 5 round pink
acetaminophen 300 mgcodeine phosphate 30 mg - 3 tv 150 round white
nadolol 80 mgbendroflumethiazide 5 mg - kpi 284 corzide 80 5 round white
lamotrigine 200 mg - lamictal xr 200 round blue
albuterol sulfate 2 mg - m 255 round white
bupropion hydrochloride 75 mg - wellbutrin 75 round yellow
carisoprodol 350 mg - dan 5513 round white
hydrochlorothiazide 50 mg - 112 s g round white
cyclophosphamide 50 mg - 54 980 round blue
benztropine mesylate 0.5 mg - cor 143 round white
norethindrone acetate 1 mgethinyl estradiol 20 ug - b 977 round yellow
perindopril erbumine 2 mg - d 5 7 round white
propranolol hydrochloride 10 mg - pliva 467 round orange
pramipexole dihydrochloride 0.25 mg - p2 round blue
amitriptyline hydrochloride 100 mg - gg461 round orange
ropinirole 2 mg - 93 5285 round pink
olanzapine 10 mg - lilly 4117 round white
trihexyphenidyl hydrochloride 2 mg - w 4 round white
repaglinide 0.5 mg - p240 round white
nifedipine 30 mg - eln 30 round brown
trandolapril 4 mg - lu h03 round red
warfarin sodium 10 mg - ig w 10 round white
bismuth subsalicylate 262 mg - ap 045 round pink
ropinirole hydrochloride 4 mg - m re4 round brown
dipyridamole 25 mg - 17 round orange
lithium carbonate 450 mg - 224 g breakline round yellow
estradiol 1 mgnorethindrone acetate 0.5 mg - novo 288 round white
venlafaxine hydrochloride 75 mg - 759 round
enalapril maleate 10 mg - elp 10 round brown
carvedilol 25 mg - g41 25 round white
metoprolol tartrate 50 mg - 477 round white
pitavastatin calcium 2 mg - 2 kc round white
folic acid 1 mg - ig 210 round yellow
meloxicam 7.5 mg - 7 5 round yellow
bupropion hydrochloride 100 mg - a 171 round yellow
chlorpromazine hydrochloride 25 mg - gg476 25 round orange
carbidopa 25 mglevodopa 250 mg - m c53 round green
pramipexole dihydrochloride 0.125 mg - 91 round white
dimenhydrinate 50 mg - 0111 v round white
chlorpromazine hydrochloride 200 mg - gg457 200 round orange
ranitidine hydrochloride 150 mg - apo ran 150 round pink
tramadol hydrochloride 50 mg - m t7 round white
citalopram hydrobromide 40 mg - 208 ig round white
carvedilol 6.25 mg - zc40 round white
labetalol hydrochloride 200 mg - cl38 200 round white
diclofenac potassium 50 mg - 93 948 round orange
fosinopril sodium 20 mg - 201 ig round white
clonazepam 0.125 mg - b 94 1 8 round white
carisoprodol 350 mg - 2410 v round white
candesartan cilexetil 8 mg - acg 008 round pink
risperidone 0.25 mg - 93 221 round yellow
tamoxifen citrate 10 mg - m 144 round white
pyridostigmine bromide 60 mg - mestinon v 60 round white
carbidopa 25 mglevodopa 100 mg - apo 131 round brown
citalopram hydrobromide 10 mg - a 05 round orange
spironolactone 100 mg - searle 1031 aldactone 100 round orange
glipizide 10 mg - 9200 teva round white
nisoldipine 17 mg - sci 501 round yellow
promethazine hydrochloride 25 mg - an 521 round white
olanzapine 7.5 mg - lilly 4116 round white
spironolactone 100 mg - 58 82 v round white
oxycodone hydrochloride 10 mg - op 10 round white
propranolol hydrochloride 80 mg - 54 86 v round yellow
amiodarone hydrochloride 100 mg - as 100 round yellow
levonorgestrel 0.050 mgethinyl estradiol 0.030 mg - dp 510 round pink
mebendazole 100 mg - 93 107 round orange
sennosides a and b 8.6 mg - az217 round brown
estradiol valerate 2 mgdienogest 3 mg - dh round yellow
amlodipine besylate 2.5 mgatorvastatin calcium trihydrate 10 mg - r 407 round white
meloxicam 15 mg - m 89 round yellow
nifedipine 60 mg - b 60 round red
methocarbamol 500 mg - west ward 290 round white
metformin hydrochloride 850 mg - bms 6070 850 round white
aspirin 81 mg - heart round yellow
aripiprazole 15 mg - a 009 15 round yellow
clomiphene citrate 50 mg - watson 781 round white
olanzapine 2.5 mg - c 45 round yellow
dexmethylphenidate hydrochloride 5 mg - 93 5276 round yellow
quinapril hydrochloride 20 mg - lu f03 round yellow
ethynodiol diacetate 1 mgethinyl estradiol 35 ug - b 14 round yellow
griseofulvin 500 mg - ortho 214 round white
cefprozil 250 mg - 93 1077 round orange
felodipine 5 mg - e137 round pink
propranolol hydrochloride 10 mg - mylan 182 10 round orange
eltrombopag olamine 25 mg - gs nx3 25 round orange
clonazepam 2 mg - b 98 2 round white
allopurinol 300 mg - m 71 round white
estradiol 0.5 mg - e 3 m round white
spironolactone 50 mg - mp 542 round white
- 3m tr 50 round white
metoprolol tartrate 100 mg - c 75 round blue
pioglitazone hydrochloride 15 mg - 31 h round white
salsalate 500 mg - bp 507 round yellow
bethanechol chloride 50 mg - lci 1329 round yellow
codeine phosphate 15 mgacetaminophen 300 mg - 2063 v 2 round white
methimazole 5 mg - bp 655 round white
tolterodine tartrate 1 mg - to round white
atovaquone 62.5 mgproguanil hydrochloride 25 mg - gx cg7 round pink
lamotrigine 200 mg - l124 round white
levonorgestrel 0.15 mgethinyl estradiol 0.03 mg - b 992 round pink
metoclopramide hydrochloride 10 mg - teva 2203 round white
venlafaxine hydrochloride 37.5 mg - 6148 v round orange
irbesartan 150 mghydrochlorothiazide 12.5 mg - 54 857 round red
diclofenac sodium 100 mg - dx 41 round pink
risedronate sodium monohydrate 35 mg - teva 7389 round orange
ethinyl estradiol 0.01 mg - tv 077 round yellow
aspirin 325 mg - aspirin 44157 round white
ropinirole hydrochloride 2 mg - 975 hh round pink
nilutamide 150 mg - 168d round white
carbidopa 25 mglevodopa 100 mg - 93 293 teva round yellow
doxycycline 100 mg - i63 round orange
testosterone 30 mg - a round white
benazepril hydrochloride 20 mg - lotensin 20 round pink
simvastatin 40 mg - rx792 round red
trifluoperazine hydrochloride 5 mg - gg55 5 round purple
albuterol sulfate 4 mg - v 4 round green
metformin hydrochloride 500 mg - a 12 round white
topiramate 200 mg - ig 281 round pink
quinidine sulfate 200 mg - dan dan 5438 round white
doxycycline 50 mg - i61 round orange
metformin hydrochloride 500 mg - 574 round white
carbamazepine 100 mg - taro 16 round white
hydrochlorothiazide 50 mg - hp 46 round white
trifluoperazine hydrochloride 5 mg - m t5 round purple
imipramine hydrochloride 50 mg - v13 lu round brown
lamotrigine 25 mg - taro lmt 25 round white
aripiprazole 10 mg - 10 18 round white
propranolol hydrochloride 80 mg - dan 5557 80 round yellow
benztropine mesylate 0.5 mg - b 1114 round white
hydrochlorothiazide 12.5 mglisinopril 10 mg - ww 62 round blue
aspirin 81 mg - 81 round yellow
doxazosin mesylate 1 mg - m d9 round white
mitotane 500 mg - bl l1 round white
lamotrigine 100 mg - par 563 round brown
cetirizine hydrochloride 5 mgpseudoephedrine hydrochloride 120 mg - 5029 5 120 round white
linagliptin 5 mg - d5 round red
estradiol 2 mg - watson 488 round green
bumetanide 2 mg - e 130 round brown
lamotrigine 25 mg - lmt 25 round white
alprazolam 2 mg - r 87 round pink
nifedipine 60 mg - ku 261 round pink
norethindrone acetate 1.5 mgethinyl estradiol 0.03 mg - watson 631 round green
doxycycline hyclate 100 mg - dan 5553 round orange
carvedilol 6.25 mg - m c32 round white
atenolol 100 mg - z 67 round white
demeclocycline hydrochloride 150 mg - an 54 round red
risperidone 0.5 mg - 93 225 round red
bethanechol chloride 50 mg - bcl 50 832 round yellow
bisacodyl 5 mg - tcl 003 round orange
bupropion hydrochloride 150 mg - 141 round white
morphine sulfate 30 mg - m 30 round purple
azilsartan kamedoxomil 80 mg - asl 80 round white
dextroamphetamine sulfate 10 mg - 953 10 b round pink
neomycin sulfate 500 mg - zynova 01 round white
quetiapine fumarate 100 mg - apo que 100 round yellow
quetiapine fumarate 200 mg - apo que 200 round white
finasteride 5 mg - ig 412 round blue
clonidine hydrochloride 0.1 mg - 241 round pink
glipizide 5 mg - gxl 5 round white
- deltasone 20 round orange
guaifenesin 600 mg - l498 round white
amlodipine besylate 5 mg - m a9 round blue
desipramine hydrochloride 10 mg - 341 round white
captopril 12.5 mg - w 7 round white
diclofenac sodium 100 mg - m 355 round yellow
metoprolol tartrate 100 mg - 93 734 round blue
anastrozole 1 mg - adx1 round white
haloperidol 10 mg - mylan 334 round green
imipramine hydrochloride 50 mg - gg 42 round green
desipramine hydrochloride 75 mg - gg166 round white
chlorpromazine hydrochloride 200 mg - 832 200 round brown
adefovir dipivoxil 10 mg - 3 round white
dipyridamole 50 mg - c82 round white
methimazole 10 mg - bp 656 round white
montelukast sodium 5 mg - 54 741 round pink
ramelteon 8 mg - tak ram 8 round orange
fluvastatin sodium 80 mg - lescol xl 80 round yellow
hyoscyamine sulfate 0.125 mg - pad h round white
azilsartan kamedoxomil 40 mgchlorthalidone 12.5 mg - ac 40 12 5 round red
clonazepam 0.5 mg - r 33 round pink
zidovudine 300 mg - 54 777 round white
lovastatin 20 mg - 20 round orange
moexipril hydrochloride 15 mg - g 208 round brown
desogestrel 0.15 mgethinyl estradiol 0.02 mg - dp 021 round white
bupropion hydrochloride 100 mg - e over 410 round blue
fosinopril sodium 40 mg - ig 202 round white
pilocarpine hydrochloride 5 mg - lan 1313 round white
hydrocodone bitartrate 7.5 mgibuprofen 200 mg - 5161 round white
bisoprolol fumarate 5 mghydrochlorothiazide 6.25 mg - e 704 round red
moexipril hydrochloride 7.5 mg - g 209 round pink
hydrocortisone 5 mg - cp 331 round white
olanzapine\ 7.5 mg - 7654 round white
metoprolol tartrate 100 mg - m 47 round blue
propranolol hydrochloride 20 mg - dan 5555 20 round blue
lisinopril 20 mghydrochlorothiazide 25 mg - lh3 m round green
spironolactone 100 mg - an 515 round brown
thioridazine hydrochloride 100 mg - mp 160 round yellow
ascorbic acid 100 mgthiamine mononitrate 1.5 mgriboflavin 1.7 mgniacinamide 20 mgpyridoxine hydrochloride 10 mgfolic acid 1 mgcobalamin 6 ugbiotin 300 ugcalcium pantothenate 10 mgzinc citrate 50 mg - h round yellow
glycopyrrolate 1 mg - k 400 round white
allopurinol 100 mg - zyloprim 100 round white
norethindrone acetate 1 mgethinyl estradiol 0.02 mg - pd 915 round white
doxazosin mesylate 2 mg - m d10 round pink
acetazolamide 125 mg - t52 round white
ribavirin 200 mg - zc19 round pink
clozapine 100 mgaspartame 12.4 mg - a08 round yellow
bisoprolol fumarate 5 mghydrochlorothiazide 6.25 mg - m 503 round blue
estropipate 3 mg - watson 416 round blue
dimethicone 125 mg - ap 040 round white
hydrocortisone 20 mg - ww 254 round white
haloperidol 2 mg - mylan 214 round orange
desipramine hydrochloride 100 mg - e 736 round blue
phenobarbital 16.2 mg - 5011 v round white
aripiprazole 15 mg - ari 15 apo round yellow
ciprofloxacin hydrochloride 250 mg - y101 round white
alprazolam 0.5 mg - r 83 round white
- 3m tr 100 round white
desmopressin acetate 0.2 mg - 0 2 37 av round white
naproxen 250 mg - ip188 250 round white
amlodipine besylate 2.5 mgatorvastatin calcium trihydrate 40 mg - pfizer cdt 254 round white
clobazam 5 mg - lu 5 round white
propafenone hydrochloride 225 mg - mp 512 round white
nifedipine 30 mg - b 30 round red
atovaquone 250 mgproguanil hydrochloride 100 mg - 404 g round pink
buprenorphine hydrochloride 2 mgnaloxone hydrochloride dihydrate 0.5 mg - 154 round white
lisinopril 20 mghydrochlorothiazide 12.5 mg - a 28 round yellow
torsemide 5 mg - pa 915 round white
penicillin v potassium 250 mg - gg949 pvk250 round white
chlorambucil 2 mg - gx eg3 l round brown
pioglitazone hydrochloride 45 mg - actos 45 round white
trazodone hydrochloride 100 mg - mp 114 round white
ketoconazole 200 mg - janssen nizoral round white
prednisone 20 mg - dan dan 5443 round orange
norethindrone 0.5 mgethinyl estradiol 0.035 mg - b 951 round yellow
hydroxyzine hydrochloride 25 mg - 3616 v round green
atenolol 50 mg - d 22 round white
finasteride 5 mg - h 37 round blue
propafenone hydrochloride 150 mg - 5124 v round white
allopurinol 300 mg - n021 round orange
metolazone 5 mg - 644 5 round blue
clopidogrel bisulfate 75 mg - apo cl 75 round pink
morphine sulfate 30 mg - m ms 30 round purple
codeine sulfate 60 mg - 60 54 412 round white
zinc acetate 2 [hp_x]zinc gluconate 2 [hp_x] - rd round red
primidone 50 mg - lan 1301 round white
lamotrigine 150 mg - j 247 round white
simvastatin 5 mg - ll c01 round brown
promethazine hydrochloride 25 mg - gg 225 round white
dimenhydrinate 50 mg - 44 198 round white
simvastatin 40 mg - ll c04 round red
doxycycline hyclate 20 mg - mp 573 round white
potassium chloride 600 mg - kc 8 round blue
chlorpromazine hydrochloride 50 mg - sz 203 round brown
- dp 519 round green
amlodipine besylate 10 mg - s25 round white
alendronate sodium 5 mg - m a6 round white
risperidone 4 mg - p 403 round white
- b 343 round pink
quetiapine fumarate 100 mg - 93 8162 round orange
guanfacine hydrochloride 1 mg - watson 444 round pink
hydrocortisone 5 mg - cortef 5 round white
acyclovir 400 mg - m 253 round white
mirtazapine 45 mg - m 545 round brown
norethindrone 0.75 mgethinyl estradiol 0.035 mg - b 942 round blue
amlodipine besylate 10 mgolmesartan medoxomil 20 mg - c74 round orange
methylphenidate hydrochloride 20 mg - dan 20 5884 round orange
betaxolol hydrochloride 20 mg - e39 round white
thyroid, porcine 15 mg - a tc round brown
busulfan 2 mg - gx ef3 m round white
solifenacin succinate 5 mg - 150 round yellow
perindopril erbumine 8 mg - d 5 9 round white
risperidone 2 mg - 93 7241 round orange
bumetanide 0.5 mg - e 128 round green
terbinafine hydrochloride 250 mg - lamisil 250 round yellow
midodrine hydrochloride 10 mg - e 149 round
isosorbide mononitrate 10 mg - 10 ku 106 round white
levothyroxine sodium 25 ug - synthroid 25 round orange
metformin hydrochloride 500 mg - 397 round white
hydrochlorothiazide 50 mg - westward 257 round orange
dextroamphetamine saccharate 5 mgamphetamine aspartate monohydrate 5 mgdextroamphetamine sulfate 5 mgamphetamine sulfate 5 mg - 2 0 dp round orange
topiramate 50 mg - m t12 round white
bupropion hydrochloride 150 mg - e over 415 round purple
liothyronine sodium 50 ug - kpi 117 round white
baclofen 10 mg - lci 1330 round white
dexmethylphenidate hydrochloride 2.5 mg - 93 5275 round blue
amiodarone hydrochloride 200 mg - as 200 round yellow
carbidopa 10 mglevodopa 100 mg - r 538 round blue
aripiprazole 20 mg - ari 20 apo round white
metronidazole 250 mg - 93 851 round white
bicalutamide 50 mg - bcm 50 round white
prednisone 20 mg - west ward 477 round red
acetaminophen 325 mgchlorpheniramine maleate 4 mgphenylephrine hydrochloride 10 mg - xl3 forte round yellow
iloperidone 12 mg - 12 round white
losartan potassium 25 mg - 11 round white
sumatriptan succinate 25 mg - m s4 round white
cyclobenzaprine hydrochloride 10 mg - pliva 563 round yellow
losartan potassium 100 mghydrochlorothiazide 25 mg - 54 557 round yellow
glycopyrrolate 2 mg - 3181 v round white
glipizide 5 mg - 9201 teva round white
bupropion hydrochloride 100 mg - m 435 round blue
aminocaproic acid 500 mg - vp 045 round white
metformin hydrochloride 850 mg - sg 106 round white
valsartan 160 mghydrochlorothiazide 12.5 mg - m v22 round orange
labetalol hydrochloride 100 mg - watson 605 round brown
guanfacine hydrochloride 3 mg - 853 round yellow
bupropion hydrochloride 150 mg - wellbutrin xl 150 round white
losartan potassium 100 mg - sz 214 round pink
citalopram hydrobromide 10 mg - rdy 342 round brown
erythromycin stearate 250 mg - es round pink
propranolol hydrochloride 80 mg - mylan 185 80 round yellow
metolazone 5 mg - zaroxolyn 5 round blue
glycopyrrolate 2 mg - horizon 205 round white
terbinafine hydrochloride 250 1 - 209 ig round white
bupropion hydrochloride 150 mg - m bu1 round green
risperidone 0.5 mg - sz z1 round pink
carbidopa 25 mglevodopa 250 mg - r 540 round blue
simvastatin 40 mg - a 03 round pink
phenazopyridine hydrochloride 200 mg - 612 round brown
doxycycline 75 mg - lci 1535 round yellow
- 405 n round pink
terbutaline sulfate 5 mg - lci 1311 round white
ketoconazole 200 milligram in 1 tablet - ket 200 apo round white
nadolol 80 mg - 80 z 4237 round white
bisoprolol fumarate 5 mg - m 523 round purple
nifedipine 90 mg - b 90 round yellow
clonazepam 1 mg - r 34 round yellow
donepezil hydrochloride 5 mg - teva 738 round white
amlodipine besylate 5 mgvalsartan 160 mg - tv j2 round yellow
cilostazol 100 mg - m c42 round white
cilostazol 50 mg - e 123 round white
diltiazem hydrochloride 30 mg - m 23 round white
ropinirole hydrochloride 8 mg - m re8 round red
enalapril maleate 2.5 mg - t 2 round yellow
morphine sulfate 15 mg - abg 15 round blue
benazepril hydrochloride 10 mg - e 53 round orange
amiloride hydrochloride 5 mghydrochlorothiazide 50 mg - 555 483 barr round yellow
desipramine hydrochloride 25 mg - 342 round blue
paroxetine hydrochloride hemihydrate 25 mg - m p4 round purple
clonidine hydrochloride 0.2 mg - r128 round orange
glipizide 10 mg - wpi 845 round white
bisoprolol fumarate 10 mg - 93 5271 round white
- b 944 round white
amitriptyline hydrochloride 50 mg - 2103 v round brown
venlafaxine hydrochloride 50 mg - zc 66 round orange
bethanechol chloride 25 mg - pliva 325 round yellow
toremifene citrate 60 mg - to 60 round white
leflunomide 10 mg - hp 43 round white
oxycodone hydrochloride 5 mg - 4810 v round white
amitriptyline hydrochloride 75 mg - 2104 v round orange
guaifenesin 400 mg - 44 532 round blue
labetalol hydrochloride 200 mg - 4365 teva round white
risperidone 0.5 mg - m r5 round brown
meclizine hydrochloride 25 mg - 21g round pink
nadolol 20 mg - kpi 232 corgard 20 round blue
ropinirole hydrochloride 2 mg - cor 204 round pink
lovastatin 20 mg - cti 142 round white
thioridazine hydrochloride 10 mg - mp 12 round yellow
clozapine 25 mg - c 7 m round orange
propafenone hydrochloride 150 mg - gs tf5 round white
melphalan 2 mg - gx eh3 a round white
dicyclomine hydrochloride 20 mg - m d6 round blue
lithium carbonate 300 mg - 54 452 round white
enalapril maleate 20 mg - m e18 round blue
acetaminophen 300 mgcodeine phosphate 30 mg - 3 m round white
bupropion hydrochloride 200 mg - 738 round white
amitriptyline hydrochloride 100 mg - m 38 round orange
primaquine phosphate 15 mg - w p97 round pink
estradiol 1 mg - watson 487 round grey
aripiprazole 20 mg - a 010 20 round white
eletriptan hydrobromide 40 mg - rep40 pfizer round orange
dexamethasone 2 mg - 54 662 round white
digoxin 250 ug - lanoxin x3a round white
fluvoxamine maleate 100 mg - e 157 round brown
lisinopril 5 mg - m l23 round orange
propranolol hydrochloride 20 mg - mylan 183 20 round blue
thioridazine hydrochloride 50 mg - m 59 50 round orange
doxazosin mesylate 1 mg - apo 093 round white
flecainide acetate 50 mg - b 859 round white
doxycycline hyclate 100 mg - ww 112 round orange
dicyclomine hydrochloride 20 mg - lan 1282 round blue
lisinopril 20 mg - w 941 round yellow
triamterene 75 mghydrochlorothiazide 50 mg - watson 348 round yellow
ondansetron 4 mg - z4 round white
propranolol hydrochloride 60 mg - mylan pr60 60 round purple
mirtazapine 30 mg - 93 7304 round white
dronabinol 10 mg - um round orange
nystatin 500000 [usp'u] - mp 83 round brown
risperidone 3 mg - sz z5 round pink
bupropion hydrochloride 200 mg - wpi 3385 round white
lisinopril 2.5 mg - watson 405 round white
lovastatin 10 mg - 926 teva round orange
oxybutynin chloride 5 mg - m o 5 round green
- 633 round white
topiramate 50 mg - ig 279 round yellow
meperidine hydrochloride 100 mg - 382 b round white
azilsartan kamedoxomil 40 mg - asl 40 round white
lovastatin 40 mg - 635 round yellow
bethanechol chloride 5 mg - bcl 5 832 round white
alendronate sodium 70 mg - 638 round white
bupropion hydrochloride 100 mg - wellbutrin sr 100 round blue
nadolol 80 mg - sz467 round white
bupropion hydrochloride 150 mg - a 133 round yellow
- 54-639 round blue
saxagliptin hydrochloride 5 mg - 5 4215 round pink
- dp 331 round green
medroxyprogesterone acetate 10 mg - provera 10 round white
metformin hydrochloride 500 mg - i45 round white
furosemide 80 mg - lasix 80 round white
clarithromycin 250 mg - 54 271 round white
methazolamide 25 mg - eff 21 round white
levonorgestrel 90 ugethinyl estradiol 20 ug - 295 watson round white
hydrochlorothiazide 25 mg - d 27 round pink
mirtazapine 15 mg - tz 1 round white
venlafaxine hydrochloride 225 mg - os304 round white
lisinopril 40 mg - rx535 round yellow
imatinib mesylate 100 mg - nvr sa round yellow
aspirin 325 mg - t round orange
lisinopril 20 mghydrochlorothiazide 12.5 mg - lh2 m round yellow
hydrocortisone 20 mg - cortef 20 round white
oxycodone hydrochloride 5 mgacetaminophen 325 mg - endo 602 round white
atenolol 50 mgchlorthalidone 25 mg - m 63 round white
metoclopramide hydrochloride 5 mg - bl 92 round white
amlodipine besylate 2.5 mg - 2108 v round white
ropinirole hydrochloride 4 mg - 977 hh round brown
phenylephrine hydrochloride 5 mg - fr4 round pink
clonidine hydrochloride 0.2 mgchlorthalidone 15 mg - m 27 round yellow
risperidone 1 mg - m r11 round white
amoxicillin 200 mgclavulanate potassium 28.5 mg - ggn2 round pink
flavoxate hydrochloride 100 mg - e58 round white
aspirin 81 mg - l467 round orange
hydroxyzine hydrochloride 50 mg - pa 309 round white
levonorgestrel 0.15 mgethinyl estradiol 0.03 mg - tv 074 round purple
donepezil hydrochloride 5 mg - 5 aricept round white
carbamazepine 100 mg - t 100 mg round yellow
bupropion hydrochloride 150 mg - g 2444 round yellow
clozapine 25 mg - clozaril 25 round yellow
phenobarbital 64.8 mg - 5013 v round white
benztropine mesylate 2 mg - cor 145 round white
tranylcypromine sulfate 10 mg - 250 k round pink
darifenacin 15 mg - df 15 round orange
olmesartan medoxomil 20 mgamlodipine besylate 5 mghydrochlorothiazide 12.5 mg - c51 round orange
escitalopram oxalate 5 mg - f 53 round white
fenofibrate 50 mg - fh 50 round white
enalapril maleate 2.5 mg - m e15 round white
diclofenac sodium 75 mg - cti 103 round white
amitriptyline hydrochloride 50 mg - gg431 round brown
hydroxyzine hydrochloride 25 mg - m h25 round blue
cyclobenzaprine hydrochloride 5 mg - m 771 round blue
glipizide 5 mg - mylan g1 round white
alendronate sodium 5 mg - a 5 round white
mirtazapine 30 mg - tz 2 round white
glipizide 2.5 mg - gxl 2 5 round blue
oxybutynin chloride 15 mg - ku 272 round white
calcium carbonate 750 mg - as round
dextroamphetamine saccharate 1.25 mgamphetamine aspartate monohydrate 1.25 mgdextroamphetamine sulfate 1.25 mgamphetamine sulfate 1.25 mg - 5 dp round white
finasteride 1 mg - 714 round red
donepezil hydrochloride 10 mg - 10 aricept round yellow
- tolinase 100 round white
nisoldipine 25.5 mg - m ne 25 round orange
desipramine hydrochloride 10 mg - e 29 round white
- 428 round orange
amitriptyline hydrochloride 50 mg - m 36 round brown
metformin hydrochloride 500 mg - e 213 round white
prednisone 5 mg - dan dan 5052 round white
donepezil hydrochloride 10 mg - x 12 round yellow
quetiapine fumarate 100 mg - seroquel 100 round yellow
ciprofloxacin hydrochloride 250 mg - p 250 round white
diclofenac potassium 50 mg - gg977 round white
amiloride hydrochloride anhydrous 5 mg - par 117 round yellow
escitalopram oxalate 20 mg - 251 ig round white
famotidine 20 mg - m f1 round yellow
lamotrigine 150 mg - l123 round white
lorazepam 0.5 mg - 240 0 5 watson round white
timolol maleate 10 mg - m 221 round green
bupropion hydrochloride 300 mg - wpi 3332 round white
fexofenadine hydrochloride 180 mg - 93 7253 round orange
flavoxate hydrochloride 100 mg - g 181 round white
bupropion hydrochloride 100 mg - 736 round white
metoprolol tartrate 25 mg - c 73 round white
naproxen sodium 220 mg - 220 round blue
atenolol 50 mg - 93 752 teva round white
oxybutynin chloride 10 mg - ku 271 round white
tiagabine hydrochloride 4 mg - c 404 round yellow
hydralazine hydrochloride 25 mg - pliva 327 round orange
famotidine 40 mg - cti 122 round white
norethindrone 1 mgethinyl estradiol 0.035 mg - b 342 round white
carbamazepine 200 mg - 109 teva round white
- dan 5552 round white
amantadine hydrochloride 100 mg - 832 amt round orange
lovastatin 40 mg - 40 round orange
clopidogrel bisulfate 75 mg - r 196 round white
glipizide 10 mg - apo glp 10 round white
pioglitazone hydrochloride 30 mg - teva 7272 round white
prochlorperazine maleate 5 mg - gg952 5 round yellow
rifaximin 200 mg - sx round pink
labetalol hydrochloride 300 mg - e118 round white
sertraline hydrochloride 25 mg - s 21 round white
flecainide acetate 100 mg - 54070 round white
chlorothiazide 250 mg - westward 209 round white
atenolol 100 mgchlorthalidone 25 mg - tenoretic 117 round white
diltiazem hydrochloride 30 mg - marion 1771 round green
acamprosate calcium 333 mg - 435 round white
escitalopram oxalate 20 mg - ig 251 round white
bupropion hydrochloride 200 mg - a161 round red
escitalopram oxalate 5 mg - ig 249 round white
prasugrel hydrochloride 5 mg - s77 round pink
bupropion hydrochloride 300 mg - a102 round white
hyoscyamine sulfate 0.125 mg - 644 round white
venlafaxine hydrochloride 37.5 mg - y02 round pink
escitalopram oxalate 10 mg - 5851 10 round white
levothyroxine sodium 0.175 mg - jsp 563 round purple
metoclopramide hydrochloride 5 mg - tv 2204 round white
acetaminophen 500 mg - fr1 round white
hyoscyamine sulfate 0.12 mgsodium phosphate, monobasic, monohydrate 40.8 mgphenyl salicylate 36.2 mgmethenamine 81.6 mgmethylene blue 10.8 mg - 293 round purple
chlorpheniramine maleate 4 mgphenylephrine hydrochloride 10 mg - 44 525 round white
demeclocycline hydrochloride 300 mg - an 55 round red
calcium acetate 667 mg - cyp910 round white
naltrexone hydrochloride 50 mg - b 50 902 round white
hydralazine hydrochloride 50 mg - pliva 328 round orange
promethazine hydrochloride 25 mg - z c 0 2 round white
pioglitazone hydrochloride 30 mgmetformin hydrochloride 1000 mg - 4833x 30 1000 round white
meprobamate 400 mg - 591 a round white
adefovir dipivoxil 10 mg - gilead 10 round white
propranolol hydrochloride 80 mg - pliva 471 round yellow
clonazepam 2 mg - 834 teva round white
fluphenazine hydrochloride 10 mg - gg490 round brown
indapamide 1.25 mg - m 69 round pink
diclofenac sodium 100 mg - gg 904 round pink
metformin hydrochloride 1000 mg - g 45 1000 round white
benztropine mesylate 2 mg - 2327 v round white
eszopiclone 3 mg - s193 round blue
trospium chloride 20 mg - l 1 round yellow
midodrine hydrochloride 10 mg - mh 3 m round white
captopril 25 mg - ww 172 round white
meperidine hydrochloride 50 mg - 381 b round white
nifedipine 30 mg - ku 260 round pink
chloroquine phosphate 500 mg - cn500 round white
venlafaxine hydrochloride 100 mg - y05 round pink
acetaminophen 300 mgcodeine phosphate 60 mg - 4 93 350 round white
risedronate sodium 150 mg - apo ris 150 round blue
lamotrigine 200 mg - lamictal 200 round white
glipizide 5 mg - wpi 844 round orange
olanzapine 5 mg - apo ola 5 round white
cyproheptadine hydrochloride 4 mg - par 043 round white
nifedipine 60 mg - eln 60 round brown
carvedilol 3.125 mg - g round white
ibuprofen 200 1 - ibu 200 round brown
bethanechol chloride 10 mg - an 572 round white
levonorgestrel 0.15 mgethinyl estradiol 0.025 mg - tv 075 round pink
naproxen sodium 275 mg - nps 275 round blue
fosinopril sodium 10 mghydrochlorothiazide 12.5 mg - i 3 round white
levothyroxine sodium 125 ug - synthroid 125 round brown
metoclopramide hydrochloride 5 mg - wpi 2228 round green
sumatriptan succinate 50 mg - sa 50 round white
venlafaxine hydrochloride 25 mg - 9 3 199 round orange
terbinafine hydrochloride 250 mg - c134 round white
acetazolamide 250 mg - lan 1050 round white
exemestane 25 mg - 2858 round white
anastrozole 1 mg - m 34 round white
desloratadine 5 mg - m d17 round red
olmesartan medoxomil 40 mgamlodipine besylate 10 mghydrochlorothiazide 12.5 mg - c55 round red
demeclocycline hydrochloride 150 mg - c 115 round pink
letrozole 2.5 mg - 54 753 round white
sumatriptan succinate 50 mg - m s7 round white
repaglinide 2 mg - 747 c round pink
prochlorperazine maleate 5 mg - 93 9643 round yellow
folic acid 1 mg - 3162 v round yellow
midodrine hydrochloride 10 mg - us 10 213 round purple
felodipine 2.5 mg - mp 771 round green
ropinirole hydrochloride 12 mg - m re12 round green
hydroxyzine hydrochloride 10 mg - 3615 v round orange
labetalol hydrochloride 200 mg - watson 606 round white
- b 143 round white
paroxetine hydrochloride hemihydrate 12.5 mg - m p3 round white
albuterol sulfate 2 mg - mp 47 round white
donepezil hydrochloride 10 mg - zf 15 round white
imipramine hydrochloride 10 mg - mp 4 round yellow
timolol maleate 5 mg - m 55 round green
amlodipine besylate 10 mg - z 5 round white
anastrozole 1 mg - teva a10 round white
morphine sulfate 30 mg - abg 30 round purple
bupropion hydrochloride 100 mg - wpi 858 round white
medroxyprogesterone acetate 5 mg - 555 873 b round white
furosemide 20 mg - 54 840 round white
hydroxyzine hydrochloride 10 mg - a 75 round white
hydroxychloroquine sulfate 200 mg - ww28 round white
hydroxyzine hydrochloride 10 mg - k 10 round white
captopril 100 mg - m c4 round white
morphine sulfate 15 mg - e652 15 round blue
dicyclomine hydrochloride 20 mg - ww 27 round blue
trihexyphenidyl hydrochloride 5 mg - dan dan 5337 round white
nifedipine 90 mg - 90 adalat cc round pink
orphenadrine citrate 100 mg - nl4 round white
desogestrel 0.15 mgethinyl estradiol 0.025 mg - b 335 round pink
amlodipine besylate 10 mgolmesartan medoxomil 40 mg - c77 round red
pilocarpine hydrochloride 7.5 mg - lci 1407 round blue
nifedipine 30 mg - m ne 30 round white
amlodipine besylate 5 mg - 2109 v round white
progesterone 100 mg - ak round pink
oxybutynin chloride 5 mg - 4853 v round blue
amlodipine besylate 2.5 mg - 237 ig round white
lovastatin 60 mg - 60 round orange
pravastatin sodium 40 mg - apo pra 40 round green
promethazine hydrochloride 50 mg - gg 235 round pink
hydrochlorothiazide 25 mg - lci 1413 round orange
diclofenac sodium 50 mg - gg738 round brown
amitriptyline hydrochloride 25 mg - gg44 round green
zafirlukast 10 mg - r 625 round pink
clonidine hydrochloride 0.2 mg - mp 658 round white
acarbose 25 mg - p210 25 round white
- deltasone 2.5 round pink
lisinopril 20 mghydrochlorothiazide 12.5 mg - rx537 round yellow
desipramine hydrochloride 50 mg - norpramin 50 round green
diclofenac sodium 75 mg - r 551 round white
drospirenone 3 mgethinyl estradiol 0.03 mg - do round yellow
nitroglycerin 0.6 mg - n 6 round white
nitroglycerin 0.4 mg - n 4 round white
nitroglycerin 0.3 mg - n 3 round white
Go PRO for all pill images
Description
The active ingredient in ranitidine hydrochloride tablets, USP 150 mg and 300 mg is ranitidine hydrochloride (HCl), USP, a histamine H2-receptor antagonist. Chemically it is N[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine, HCl. It has the following structure:
The empirical formula is C13H22N4O3S•HCl, representing a molecular weight of 350.87.
Ranitidine HCl is a white to pale yellow, granular substance that is soluble in water. It has a slightly bitter taste and sulfur like odor.
Each ranitidine tablet, USP 150 mg for oral administration contains 168 mg of ranitidine HCl equivalent to 150 mg of ranitidine. Each tablet also contains the inactive ingredients hypromellose 2910/5cP, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide, and synthetic yellow iron oxide.
Each ranitidine tablets, USP 300 mg for oral administration contains 336 mg of ranitidine HCl equivalent to 300 mg of ranitidine. Each tablet also contains the inactive ingredients hypromellose 2910/5cP, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide, and synthetic yellow iron oxide.
Clinical Pharmacology
Ranitidine is a competitive, reversible inhibitor of the action of histamine at the histamine H2-receptors, including receptors on the gastric cells. Ranitidine does not lower serum Ca++ in hypercalcemic states. Ranitidine is not an anticholinergic agent.Pharmacokinetics
Absorption
Ranitidine is 50% absorbed after oral administration, compared to an intravenous (IV) injection with mean peak levels of 440 to 545 ng/mL occurring 2 to 3 hours after a 150 mg dose. Absorption is not significantly impaired by the administration of food or antacids. Propantheline slightly delays and increases peak blood levels of ranitidine, probably by delaying gastric emptying and transit time. In one study, simultaneous administration of high-potency antacid (150 mmol) in fasting subjects has been reported to decrease the absorption of ranitidine.Distribution
The volume of distribution is about 1.4 L/kg. Serum protein binding averages 15%.Metabolism
In humans, the N-oxide is the principal metabolite in the urine; however, this amounts to <4% of the dose. Other metabolites are the S-oxide (1%) and the desmethyl ranitidine (1%). The remainder of the administered dose is found in the stool. Studies in patients with hepatic dysfunction (compensated cirrhosis) indicate that there are minor, but clinically insignificant, alterations in ranitidine half-life, distribution, clearance, and bioavailability.Excretion
The principal route of excretion is the urine, with approximately 30% of the orally administered dose collected in the urine as unchanged drug in 24 hours. Renal clearance is about 410 mL/min, indicating active tubular excretion. The elimination half-life is 2.5 to 3 hours. Four patients with clinically significant renal function impairment (creatinine clearance 25 to 35 mL/min) administered 50 mg of ranitidine intravenously had an average plasma half-life of 4.8 hours, a ranitidine clearance of 29 mL/min, and a volume of distribution of 1.76 L/kg. In general, these parameters appear to be altered in proportion to creatinine clearance (see DOSAGE AND ADMINISTRATION).Geriatrics
The plasma half-life is prolonged and total clearance is reduced in the elderly population due to a decrease in renal function. The elimination half-life is 3 to 4 hours. Peak levels average 526 ng/mL following a 150 mg twice daily dose and occur in about 3 hours (see PRECAUTIONS: Geriatric Use and DOSAGE AND ADMINISTRATION: Dosage Adjustment for Patients with Impaired Renal Function).Pediatrics
There are no significant differences in the pharmacokinetic parameter values for ranitidine in pediatric patients (from 1 month up to 16 years of age) and healthy adults when correction is made for body weight. The average bioavailability of ranitidine given orally to pediatric patients is 48% which is comparable to the bioavailability of ranitidine in the adult population. All other pharmacokinetic parameter values (t½, Vd, and CL) are similar to those observed with intravenous ranitidine use in pediatric patients. Estimates of Cmax and Tmax are displayed in Table 1.
Table 1. Ranitidine Pharmacokinetics in Pediatric Patients Following Oral Dosing Population(age) n Dosage Form(dose) Cmax(ng/mL) Tmax(hours) Gastric or duodenal ulcer Tablets (3.5 to 16 years) 12 (1 to 2 mg/kg) 54 to 492 2.0 Otherwise healthy requiring ranitidine(0.7 to 14 years, Single dose) 10 Syrup(2 mg/kg) 244 1.61 Otherwise healthy requiring ranitidine(0.7 to 14 years, Multiple dose) 10 Syrup(2 mg/kg) 320 1.66
Plasma clearance measured in two neonatal patients (less than 1 month of age) was considerably lower (3 mL/min/kg) than children or adults and is likely due to reduced renal function observed in this population (see PRECAUTIONS: Pediatric Use and DOSAGE AND ADMINISTRATION: Pediatric Use).Pharmacodynamics
Serum concentrations necessary to inhibit 50% of stimulated gastric acid secretion are estimated to be 36 to 94 ng/mL. Following a single oral dose of 150 mg, serum concentrations of ranitidine are in this range up to 12 hours. However, blood levels bear no consistent relationship to dose or degree of acid inhibition.Antisecretory Activity
1. Effects on Acid Secretion
Ranitidine inhibits both daytime and nocturnal basal gastric acid secretions as well as gastric acid secretion stimulated by food, betazole, and pentagastrin, as shown in Table 2.
Table 2. Effect of Oral Ranitidine on Gastric Acid Secretion  Time After Dose, h % Inhibition of Gastric Acid Output by Dose, mg 75-80 100 150 200 Basal Up to 4 99 95 Nocturnal Up to 13 95 96 92 Betazole Up to 3 97 99 Pentagastrin Up to 5 58 72 72 80 Meal Up to 3 73 79 95
It appears that basal-, nocturnal-, and betazole-stimulated secretions are most sensitive to inhibition by ranitidine, responding almost completely to doses of 100 mg or less, while pentagastrin- and food-stimulated secretions are more difficult to suppress.2. Effects on Other Gastrointestinal Secretions
Pepsin: Oral ranitidine does not affect pepsin secretion. Total pepsin output is reduced in proportion to the decrease in volume of gastric juice. Intrinsic Factor: Oral ranitidine has no significant effect on pentagastrin-stimulated intrinsic factor secretion. Serum Gastrin: Ranitidine has little or no effect on fasting or postprandial serum gastrin. Pepsin
Oral ranitidine does not affect pepsin secretion. Total pepsin output is reduced in proportion to the decrease in volume of gastric juice.Intrinsic Factor
Oral ranitidine has no significant effect on pentagastrin-stimulated intrinsic factor secretion.Serum Gastrin
Ranitidine has little or no effect on fasting or postprandial serum gastrin.Other Pharmacologic Actions
a. Gastric bacterial flora - increase in nitrate-reducing organisms, significance not known.b. Prolactin levels - no effect in recommended oral or intravenous (IV) dosage, but small, transient, dose-related increases in serum prolactin have been reported after IV bolus injections of 100 mg or more.c. Other pituitary hormones - no effect on serum gonadotropins, TSH, or GH. Possible impairment of vasopressin release.d. No change in cortisol, aldosterone, androgen, or estrogen levels.e. No antiandrogenic action.f. No effect on count, motility, or morphology of sperm.Pediatrics
Oral doses of 6 to 10 mg/kg per day in two or three divided doses maintain gastric pH>4 throughout most of the dosing interval.Clinical Trials: Active Duodenal Ulcer
In a multicenter, double-blind, controlled, US study of endoscopically diagnosed duodenal ulcers, earlier healing was seen in the patients treated with ranitidine as shown in Table 3.
Table 3. Duodenal Ulcer Patient Healing Rates Ranitidine All patients were permitted p.r.n. antacids for relief of pain. Placebo Number Entered Healed/Evaluable Number Entered Healed/Evaluable Outpatients Week 2 195 69/182(38%) P<0.0001. 188 31/164 (19%) Week 4 137/187 (73%) 76/168 (45%)
In these studies, patients treated with ranitidine reported a reduction in both daytime and nocturnal pain, and they also consumed less antacid than the placebo-treated patients.
Table 4. Mean Daily Doses of Antacid Ulcer Healed Ulcer Not Healed Ranitidine 0.06 0.71 Placebo 0.71 1.43
Foreign studies have shown that patients heal equally well with 150 mg b.i.d. and 300 mg h.s. (85% versus 84%, respectively) during a usual 4-week course of therapy. If patients require extended therapy of 8 weeks, the healing rate may be higher for 150 mg b.i.d. as compared to 300 mg h.s. (92% versus 87%, respectively).
Studies have been limited to short-term treatment of acute duodenal ulcer. Patients whose ulcers healed during therapy had recurrences of ulcers at the usual rates.Maintenance Therapy in Duodenal Ulcer
Ranitidine has been found to be effective as maintenance therapy for patients following healing of acute duodenal ulcers. In two independent, double-blind, multicenter, controlled trials, the number of duodenal ulcers observed was significantly less in patients treated with ranitidine (150 mg h.s.) than in patients treated with placebo over a 12-month period.
Table 5. Duodenal Ulcer Prevalence Double-blind, Multicenter, Placebo-Controlled Trials Multicenter Trial Drug Duodenal Ulcer Prevalence No. of Patients 0-4 Months 0-8 Months 0-12 Months % = Life table estimate. RAN = ranitidine. PLC = placebo. USA RAN 20% = P<0.05 (ranitidine versus comparator). 24% 35% 138 PLC 44% 54% 59% 139 Foreign RAN 12% 21% 28% 174 PLC 56% 64% 68% 165
As with other H2-antagonists, the factors responsible for the significant reduction in the prevalence of duodenal ulcers include prevention of recurrence of ulcers, more rapid healing of ulcers that may occur during maintenance therapy, or both.Gastric Ulcer
In a multicenter, double-blind, controlled, US study of endoscopically diagnosed gastric ulcers, earlier healing was seen in the patients treated with ranitidine as shown in Table 6.
Table 6. Gastric Ulcer Patient Healing Rates Ranitidine All patients were permitted p.r.n. antacids for relief of pain. Placebo  Number Entered Healed/Evaluable Number Entered Healed/Evaluable Outpatients Week 2 92 16/83 (19%) 94 10/83 (12%) Week 6 50/73 (68%) P = 0.009. 35/69 (51%)
In this multicenter trial, significantly more patients treated with ranitidine became pain free during therapy.Maintenance of Healing of Gastric Ulcers
In two multicenter, double-blind, randomized, placebo-controlled, 12-month trials conducted in patients whose gastric ulcers had been previously healed, ranitidine 150 mg h.s. was significantly more effective than placebo in maintaining healing of gastric ulcers.Pathological Hypersecretory Conditions (such as Zollinger-Ellison syndrome)
Ranitidine inhibits gastric acid secretion and reduces occurrence of diarrhea, anorexia, and pain in patients with pathological hypersecretion associated with Zollinger-Ellison syndrome, systemic mastocytosis, and other pathological hypersecretory conditions (e.g., postoperative, "short-gut" syndrome, idiopathic). Use of ranitidine was followed by healing of ulcers in 8 of 19 (42%) patients who were intractable to previous therapy.Gastroesophageal Reflux Disease (GERD)
In two multicenter, double-blind, placebo-controlled, 6-week trials performed in the United States and Europe, ranitidine 150 mg b.i.d. was more effective than placebo for the relief of heartburn and other symptoms associated with GERD. Ranitidine-treated patients consumed significantly less antacid than did placebo-treated patients.
The US trial indicated that ranitidine 150 mg b.i.d. significantly reduced the frequency of heartburn attacks and severity of heartburn pain within 1 to 2 weeks after starting therapy. The improvement was maintained throughout the 6-week trial period. Moreover, patient response rates demonstrated that the effect on heartburn extends through both the day and night time periods.
In two additional US multicenter, double-blind, placebo-controlled, 2-week trials, ranitidine 150 mg b.i.d. was shown to provide relief of heartburn pain within 24 hours of initiating therapy and a reduction in the frequency of severity of heartburn.Erosive Esophagitis
In two multicenter, double-blind, randomized, placebo-controlled, 12-week trials performed in the United States, ranitidine 150 mg q.i.d. was significantly more effective than placebo in healing endoscopically diagnosed erosive esophagitis and in relieving associated heartburn. The erosive esophagitis healing rates were as follows:
Table 7. Erosive Esophagitis Patient Healing Rates Healed/Evaluable Placebo All patients were permitted p.r.n. antacids for relief of pain. n = 229Ranitidine150 mg q.i.d. n = 215 Week 4 43/198 (22%) 96/206 (47%) P<0.001 versus placebo. Week 8 63/176 (36%) 142/200 (71%) Week12 92/159 (58%) 162/192 (84%)
No additional benefit in healing of esophagitis or in relief of heartburn was seen with a ranitidine dose of 300 mg q.i.d.Maintenance of Healing of Erosive Esophagitis
In two multicenter, double-blind, randomized, placebo-controlled, 48-week trials conducted in patients whose erosive esophagitis had been previously healed, ranitidine 150 mg b.i.d. was significantly more effective than placebo in maintaining healing of erosive esophagitis.
Indications And Usage
Ranitidine is indicated in:
- Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks.
- Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers. No placebo-controlled comparative studies have been carried out for periods of longer than 1 year.
- The treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome and systemic mastocytosis).
- Short-term treatment of active, benign gastric ulcer. Most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated. Studies available to date have not assessed the safety of ranitidine in uncomplicated, benign gastric ulcer for periods of more than 6 weeks.
- Maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers. Placebo-controlled studies have been carried out for 1 year.
- Treatment of GERD. Symptomatic relief commonly occurs within 24 hours after starting therapy with ranitidine 150 mg b.i.d.
- Treatment of endoscopically diagnosed erosive esophagitis. Symptomatic relief of heartburn commonly occurs within 24 hours of therapy initiation with ranitidine 150 mg q.i.d.
- Maintenance of healing of erosive esophagitis. Placebo-controlled trials have been carried out for 48 weeks.
Concomitant antacids should be given as needed for pain relief to patients with active duodenal ulcer; active, benign gastric ulcer; hypersecretory states; GERD; and erosive esophagitis.
Contraindications
Ranitidine is contraindicated for patients known to have hypersensitivity to the drug or any of the ingredients (see PRECAUTIONS).
Precautions
General
- Symptomatic response to therapy with ranitidine does not preclude the presence of gastric malignancy.
- Since ranitidine is excreted primarily by the kidney, dosage should be adjusted in patients with impaired renal function (see DOSAGE AND ADMINISTRATION). Caution should be observed in patients with hepatic dysfunction since ranitidine is metabolized in the liver.
- Rare reports suggest that ranitidine may precipitate acute porphyric attacks in patients with acute porphyria. Ranitidine should therefore be avoided in patients with a history of acute porphyria.
Laboratory Tests
False-positive tests for urine protein with MULTISTIX® may occur during ranitidine therapy, and therefore testing with sulfosalicylic acid is recommended.Drug Interactions
Although ranitidine has been reported to bind weakly to cytochrome P-450 in vitro, recommended doses of the drug do not inhibit the action of the cytochrome P-450-linked oxygenase enzymes in the liver. However, there have been isolated reports of drug interactions that suggest that ranitidine may affect the bioavailability of certain drugs by some mechanism as yet unidentified (e.g., a pH-dependent effect on absorption or a change in volume of distribution).
Increased or decreased prothrombin times have been reported during concurrent use of ranitidine and warfarin. However, in human pharmacokinetic studies with dosages of ranitidine up to 400 mg/day, no interaction occurred; ranitidine had no effect on warfarin clearance or prothrombin time. The possibility of an interaction with warfarin at dosages of ranitidine higher than 400 mg/day has not been investigated.
In a ranitidine-triazolam drug-drug interaction study, triazolam plasma concentrations were higher during b.i.d. dosing of ranitidine than triazolam given alone. The mean area under the triazolam concentration-time curve (AUC) values in 18- to 60-year-old subjects were 10% and 28% higher following administration of 75 mg and 150 mg ranitidine tablets, respectively, than triazolam given alone. In subjects older than 60 years of age, the mean AUC values were approximately 30% higher following administration of 75 mg and 150 mg ranitidine tablets. It appears that there were no changes in pharmacokinetics of triazolam and α-hydroxytriazolam, a major metabolite, and in their elimination. Reduced gastric acidity due to ranitidine may have resulted in an increase in the availability of triazolam. The clinical significance of this triazolam and ranitidine pharmacokinetic interaction is unknown.Carcinogenesis, Mutagenesis, Impairment of Fertility
There was no indication of tumorigenic or carcinogenic effects in life-span studies in mice and rats at dosages up to 2,000 mg/kg per day.
Ranitidine was not mutagenic in standard bacterial tests (Salmonella, Escherichia coli) for mutagenicity at concentrations up to the maximum recommended for these assays.
In a dominant lethal assay, a single oral dose of 1,000 mg/kg to male rats was without effect on the outcome of two matings per week for the next 9 weeks.Pregnancy
Teratogenic Effects
Pregnancy Category B. Reproduction studies have been performed in rats and rabbits at doses up to 160 times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to ranitidine. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.Nursing Mothers
Ranitidine is secreted in human milk. Caution should be exercised when ranitidine is administered to a nursing mother.Pediatric Use
The safety and effectiveness of ranitidine have been established in the age-group of 1 month to 16 years for the treatment of duodenal and gastric ulcers, gastrooesophageal reflux disease and erosive esophagitis, and the maintenance of healed duodenal and gastric ulcer. Use of ranitidine in this age-group is supported by adequate and well-controlled studies in adults, as well as additional pharmacokinetic data in pediatric patients and an analysis of the published literature (see CLINICAL PHARMACOLOGY: Pediatrics and DOSAGE AND ADMINISTRATION: Pediatric Use).
Safety and effectiveness in pediatric patients for the treatment of pathological hypersecretory conditions or the maintenance of healing of erosive esophagitis have not been established.
Safety and effectiveness in neonates (less than one month of age) have not been established (see CLINICAL PHARMACOLOGY: Pediatrics).Geriatric Use
Of the total number of subjects enrolled in US and foreign controlled clinical trials of oral formulations of ranitidine, for which there were subgroup analyses, 4,197 were 65 and over, while 899 were 75 and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
This drug is known to be substantially excreted by the kidney and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, caution should be exercised in dose selection, and it may be useful to monitor renal function (see CLINICAL PHARMACOLOGY: Pharmacokinetics: Geriatrics and DOSAGE AND ADMINISTRATION: Dosage Adjustment for Patients with Impaired Renal Function).
Adverse Reactions
The following have been reported as events in clinical trials or in the routine management of patients treated with ranitidine. The relationship to therapy with ranitidine has been unclear in many cases. Headache, sometimes severe, seems to be related to administration of ranitidine.
Central Nervous System: Rarely, malaise, dizziness, somnolence, insomnia, and vertigo. Rare cases of reversible mental confusion, agitation, depression, and hallucinations have been reported, predominantly in severely ill elderly patients. Rare cases of reversible blurred vision suggestive of a change in accommodation have been reported. Rare reports of reversible involuntary motor disturbances have been received.
Cardiovascular: As with other H2-blockers, rare reports of arrhythmias such as tachycardia, bradycardia, atrioventricular block, and premature ventricular beats.
Gastrointestinal: Constipation, diarrhea, nausea/vomiting, abdominal discomfort/pain, and rare reports of pancreatitis.
Hepatic: There have been occasional reports of hepatocellular, cholestatic, or mixed hepatitis, with or without jaundice. In such circumstances, ranitidine should be immediately discontinued. These events are usually reversible, but in rare circumstances death has occurred. Rare cases of hepatic failure have also been reported. In normal volunteers, SGPT values were increased to at least twice the pretreatment levels in 6 of 12 subjects receiving 100 mg q.i.d. intravenously for 7 days, and in 4 of 24 subjects receiving 50 mg q.i.d. intravenously for 5 days.
Musculoskeletal: Rare reports of arthralgias and myalgias.
Hematologic: Blood count changes (leukopenia, granulocytopenia, and thrombocytopenia) have occurred in a few patients. These were usually reversible. Rare cases of agranulocytosis, pancytopenia, sometimes with marrow hypoplasia, and aplastic anemia and exceedingly rare cases of acquired immune hemolytic anemia have been reported.
Endocrine: Controlled studies in animals and man have shown no stimulation of any pituitary hormone by ranitidine and no antiandrogenic activity, and cimetidine-induced gynecomastia and impotence in hypersecretory patients have resolved when ranitidine has been substituted. However, occasional cases of gynecomastia, impotence, and loss of libido have been reported in male patients receiving ranitidine, but the incidence did not differ from that in the general population.
Integumentary: Rash, including rare cases of erythema multiforme. Rare cases of alopecia and vasculitis.
Other: Rare cases of hypersensitivity reactions (e.g., bronchospasm, fever, rash, eosinophilia), anaphylaxis, angioneurotic edema, and small increases in serum creatinine.
Overdosage
There has been limited experience with overdosage. Reported acute ingestions of up to 18 g orally have been associated with transient adverse effects similar to those encountered in normal clinical experience (see ADVERSE REACTIONS). In addition, abnormalities of gait and hypotension have been reported.
When overdosage occurs, the usual measures to remove unabsorbed material from the gastrointestinal tract, clinical monitoring, and supportive therapy should be employed.
Studies in dogs receiving dosages of ranitidine in excess of 225 mg/kg per day have shown muscular tremors, vomiting, and rapid respiration. Single oral doses of 1,000 mg/kg in mice and rats were not lethal. Intravenous LD50 values in mice and rats were 77 and 83 mg/kg, respectively.
Dosage And Administration
Active Duodenal Ulcer
The current recommended adult oral dosage of ranitidine for duodenal ulcer is 150 mg twice daily. An alternative dosage of 300 mg once daily after the evening meal or at bedtime can be used for patients in whom dosing convenience is important. The advantages of one treatment regimen compared to the other in a particular patient population have yet to be demonstrated (see Clinical Trials: Active Duodenal Ulcer). Smaller doses have been shown to be equally effective in inhibiting gastric acid secretion in US studies, and several foreign trials have shown that 100 mg twice daily is as effective as the 150 mg dose.
Antacid should be given as needed for relief of pain (see CLINICAL PHARMACOLOGY: Pharmacokinetics).Maintenance of Healing of Duodenal Ulcers
The current recommended adult oral dosage is 150 mg at bedtime.Pathological Hypersecretory Conditions (such as Zollinger-Ellison syndrome)
The current recommended adult oral dosage is 150 mg twice a day. In some patients it may be necessary to administer ranitidine 150 mg doses more frequently. Dosages should be adjusted to individual patient needs, and should continue as long as clinically indicated. Dosages up to 6 g/day have been employed in patients with severe disease.Benign Gastric Ulcer
The current recommended adult oral dosage is 150 mg twice a day.Maintenance of Healing of Gastric Ulcers
The current recommended adult oral dosage is 150 mg at bedtime.GERD
The current recommended adult oral dosage is 150 mg twice a day.Erosive Esophagitis
The current recommended adult oral dosage is 150 mg four times a day.Maintenance of Healing of Erosive Esophagitis
The current recommended adult oral dosage is 150 mg twice a day.Pediatric Use
The safety and effectiveness of ranitidine have been established in the age-group of 1 month to 16 years. There is insufficient information about the pharmacokinetics of ranitidine in neonatal patients (less than 1 month of age) to make dosing recommendations.
The following 3 subsections provide dosing information for each of the pediatric indications.Treatment of Duodenal and Gastric Ulcers
The recommended oral dose for the treatment of active duodenal and gastric ulcers is 2 to 4 mg/kg twice daily to a maximum of 300 mg/day. This recommendation is derived from adult clinical studies and pharmacokinetic data in pediatric patients.Maintenance of Healing of Duodenal and Gastric Ulcers
The recommended oral dose for the maintenance of healing of duodenal and gastric ulcers is 2 to 4 mg/kg once daily to a maximum of 150 mg/day. This recommendation is derived from adult clinical studies and pharmacokinetic data in pediatric patients.Treatment of GERD and Erosive Esophagitis
Although limited data exist for these conditions in pediatric patients, published literature supports a dosage of 5 to 10 mg/kg per day, usually given as two divided doses.Dosage Adjustment for Patients With Impaired Renal Function
On the basis of experience with a group of subjects with severely impaired renal function treated with ranitidine, the recommended dosage in patients with a creatinine clearance <50 mL/min is 150 mg every 24 hours. Should the patient's condition require, the frequency of dosing may be increased to every 12 hours or even further with caution. Hemodialysis reduces the level of circulating ranitidine. Ideally, the dosing schedule should be adjusted so that the timing of a scheduled dose coincides with the end of hemodialysis.
Elderly patients are more likely to have decreased renal function, therefore caution should be exercised in dose selection, and it may be useful to monitor renal function (see CLINICAL PHARMACOLOGY: Pharmacokinetics: Geriatrics and PRECAUTIONS: Geriatric Use).
How Supplied
Ranitidine tablets, USP 150 mg (ranitidine hydrochloride USP equivalent to 150 mg of ranitidine) are yellow colored, round, biconvex film coated tablets, embossed 'C108' on one side and plain on other side and are supplied in bottles of 30, 60, 90, 100, 180, 250, 500, 1000 and unit dose packages of 100 (10 × 10).
Bottles of 30 NDC 55111-420-30 Bottles of 60 NDC 55111-420-60 Bottles of 90 NDC 55111-420-90 Bottles of 100 NDC 55111-420-01 Bottles of 180 NDC 55111-420-18 Bottles of 250 NDC 55111-420-25 Bottles of 500 NDC 55111-420-05 Bottles of 1000 NDC 55111-420-10 Unit dose package of 100 (10 × 10) NDC 55111-420-78
Ranitidine tablets, USP 300 mg (ranitidine hydrochloride USP equivalent to 300 mg of ranitidine) are yellow colored, capsule shaped, biconvex plain film coated tablets and are supplied in bottles of 30, 60, 90, 100, 180, 250, 500 and unit dose packages of 100 (10 × 10).
Bottles of 30 NDC 55111-421-30 Bottles of 60 NDC 55111-421-60 Bottles of 90 NDC 55111-421-90 Bottles of 100 NDC 55111-420-01 Bottles of 180 NDC 55111-421-18 Bottles of 250 NDC 55111-420-25 Bottles of 500 NDC 55111-421-05 Unit dose package of 100 (10 × 10) NDC 55111-421-78 STORAGE AND HANDLING SECTION
Store at 20°-25°C (68°-77°F) (See USP Controlled Room Temperature). Protect from light. Replace cap securely after each opening and retain bulers in carton until time of use.
Manufactured by:Dr. Reddy's Laboratories LimitedBachepalli - 502325 INDIA
Issued: 1005
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
